Choong-wae launches treatment for dysuria associated with benign prostatic hyperplasia

Choong-wae Pharm said it has recently launched Thrupas (silodosin), a new α1-adrenoceptor antagonist with high uroselectivity

By selectively blocking alpha 1A-adrenoceptors that primarily exist in the prostate gland, silodosin, removes the tension of the prostate gland to improve urethral resistance, thereby improving dysuria associated with BPH.

Compared with existing drugs, silodosin o...